SIBN
Price
$16.69
Change
-$0.23 (-1.36%)
Updated
Jan 17 closing price
Capitalization
672.23M
44 days until earnings call
VAPO
Price
$2.17
Change
-$0.01 (-0.46%)
Updated
Sep 19 closing price
Capitalization
18.42M
Ad is loading...

SIBN vs VAPO

Header iconSIBN vs VAPO Comparison
Open Charts SIBN vs VAPOBanner chart's image
SI-BONE
Price$16.69
Change-$0.23 (-1.36%)
Volume$294.44K
Capitalization672.23M
Vapotherm
Price$2.17
Change-$0.01 (-0.46%)
Volume$51.53K
Capitalization18.42M
SIBN vs VAPO Comparison Chart
Loading...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SIBN vs. VAPO commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SIBN is a Hold and VAPO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (SIBN: $16.69 vs. VAPO: $2.17)
Brand notoriety: SIBN and VAPO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SIBN: 87% vs. VAPO: 100%
Market capitalization -- SIBN: $672.23M vs. VAPO: $18.42M
SIBN [@Medical Specialties] is valued at $672.23M. VAPO’s [@Medical Specialties] market capitalization is $18.42M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SIBN’s FA Score shows that 0 FA rating(s) are green whileVAPO’s FA Score has 1 green FA rating(s).

  • SIBN’s FA Score: 0 green, 5 red.
  • VAPO’s FA Score: 1 green, 4 red.
According to our system of comparison, both SIBN and VAPO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SIBN’s TA Score shows that 4 TA indicator(s) are bullish.

  • SIBN’s TA Score: 4 bullish, 4 bearish.

Price Growth

SIBN (@Medical Specialties) experienced а +21.65% price change this week, while VAPO (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +1.30%.

Reported Earning Dates

SIBN is expected to report earnings on May 12, 2025.

VAPO is expected to report earnings on Nov 08, 2023.

Industries' Descriptions

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIBN($672M) has a higher market cap than VAPO($18.4M). SIBN YTD gains are higher at: 19.044 vs. VAPO (0.000). SIBN has higher annual earnings (EBITDA): -34.45M vs. VAPO (-47.02M). SIBN has more cash in the bank: 166M vs. VAPO (14.4M). SIBN has less debt than VAPO: SIBN (39M) vs VAPO (107M). SIBN has higher revenues than VAPO: SIBN (139M) vs VAPO (67.6M).
SIBNVAPOSIBN / VAPO
Capitalization672M18.4M3,652%
EBITDA-34.45M-47.02M73%
Gain YTD19.0440.000-
P/E RatioN/AN/A-
Revenue139M67.6M206%
Total Cash166M14.4M1,153%
Total Debt39M107M36%
FUNDAMENTALS RATINGS
SIBN vs VAPO: Fundamental Ratings
SIBN
VAPO
OUTLOOK RATING
1..100
1550
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
4141
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VAPO's Valuation (33) in the Medical Specialties industry is in the same range as SIBN (43). This means that VAPO’s stock grew similarly to SIBN’s over the last 12 months.

VAPO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SIBN (100). This means that VAPO’s stock grew similarly to SIBN’s over the last 12 months.

SIBN's SMR Rating (95) in the Medical Specialties industry is in the same range as VAPO (100). This means that SIBN’s stock grew similarly to VAPO’s over the last 12 months.

SIBN's Price Growth Rating (41) in the Medical Specialties industry is in the same range as VAPO (41). This means that SIBN’s stock grew similarly to VAPO’s over the last 12 months.

SIBN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as VAPO (100). This means that SIBN’s stock grew similarly to VAPO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SIBN
RSI
ODDS (%)
Bearish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
74%
Momentum
ODDS (%)
Bullish Trend 5 days ago
77%
MACD
ODDS (%)
Bullish Trend 5 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 20 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
73%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with QTRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then QTRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
-1.36%
QTRX - SIBN
46%
Loosely correlated
+0.57%
NVRO - SIBN
45%
Loosely correlated
+1.56%
AORT - SIBN
43%
Loosely correlated
-1.66%
LAB - SIBN
43%
Loosely correlated
+2.31%
KIDS - SIBN
41%
Loosely correlated
+2.37%
More

VAPO and

Correlation & Price change

A.I.dvisor tells us that VAPO and NVYTF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VAPO and NVYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VAPO
1D Price
Change %
VAPO100%
N/A
NVYTF - VAPO
26%
Poorly correlated
N/A
SIBN - VAPO
7%
Poorly correlated
-1.36%
BWAY - VAPO
1%
Poorly correlated
-0.87%
STIM - VAPO
0%
Poorly correlated
+7.89%
PSNL - VAPO
-1%
Poorly correlated
+2.30%
More